CoreAge Rx vs WellMedRx
Six dollars a month apart — and one of them tells you whether you are buying 500 or 1,000 milligrams.
Updated
Disclosure: NAD Picks is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. Partners are listed first; commissions do not change evidence scores or editorial verdicts. How we make money.
CoreAge Rx
Partner
$93/mo
The cheapest NAD⁺ injection we can verify, at a published $93 a month for either the shot or the nasal spray, with the compounding stated on the product page.
Pick it for: A price you can read on the product page, a nasal spray at the same rate, and free delivery
WellMedRx
Editorial
$99/mo
States 500 and 1,000 mg and promises the price does not move with the dose — at $99 a month — level with Embody and Mondae, just above CoreAge at $93 — behind a banner advertising a discount rather than a price.
Pick it for: $6 a month for a stated 500 mg or 1,000 mg, once the ongoing rate is confirmed
Our verdict
CoreAge Rx is $93 and WellMedRx is $99, a gap of $6 a month, which is very little set against what the second one discloses: 500 mg and 1,000 mg injection options, stated twice on its page, with the price held flat across doses. Take the 1,000 mg and that is about ten cents a milligram; CoreAge publishes no quantity, so its $93 cannot be placed next to that or next to anything else. The caution runs the other way on confirmability. CoreAge's $93 sits on a product page you can read before any intake, while WellMedRx has no tier table, no purchasable NAD⁺ listing, and a banner offering up to $150 off that nothing on the page explains next to a $99 price — so its rate is stated rather than verified at a checkout. Both display a LegitScript certification and both sell compounded NAD⁺ the FDA has not reviewed; for $6, get WellMedRx to put month two in writing and take the milligrams.
What actually separates them
CoreAge Rx and WellMedRx state different things about published price and states a milligram dose. Everything else they publish, they publish the same way.
WellMedRx costs $6 more than CoreAge Rx — 6% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $1,116 at CoreAge Rx against $1,188 at WellMedRx — a difference of $72.
| CoreAge Rx | WellMedRx | |
|---|---|---|
| Published price | $93/mo | $99/mo |
| States a milligram dose | No | Yes |
Where they differ on what they tell you
Price is the easy comparison and often the least useful one. These are the places where one of these two answers a question the other leaves open.
- Milligrams
- WellMedRx publishes how much NAD⁺ you get; CoreAge Rx does not, so $93 at CoreAge Rx buys a quantity nobody has told you.
- Routes offered
- CoreAge Rx also sells a nasal spray, while WellMedRx offers only a subcutaneous injection — which matters if you change your mind about the format later.
- The gap, over a year
- On the injection both sell, CoreAge Rx at $93 against WellMedRx at $99 is 6% — about $72 a year, if you stay on either for twelve months and neither price moves.
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Both sell a compounded drug and neither names the pharmacy that compounds it.
- Neither states whether any bloodwork is included, or what it would cost.
Before you choose either
Only one of these two publishes a milligram dose, which makes a straight price comparison impossible: you can tell what each costs, but only one tells you what you get. Ask the other what dose its price buys before you commit, then put both numbers through our cost-per-milligram calculator. A seller that will not answer that question has told you something.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.